facebook twitter linkedin instagram youtube spotify
×
<
>
loading_icra
bg-rating-rationales

Entity-Specific Rating Rationales

02 Apr 2025

Bafna Pharmaceuticals Limited: Ratings reaffirmed

Bafna Pharmaceuticals Limited: Ratings reaffirmed

bg-rating-crediet-reports

Entity-Specific Credit Perspective Reports

30 May 2008

Bafna Pharmaceuticals Limited

Bafna Pharmaceuticals Limited (Non-SF)

Ratings

Description
Short Term
Medium Term
Long Term
Issuer
Term Loan -- -- [ICRA]BB+(Stable) --
Long Term – Unallocated -- -- [ICRA]BB+(Stable) --
Short term non-fund-based facilities – Letter of Credit [ICRA]A4+ -- -- --
Long Term - Fund based -Cash Credit -- -- [ICRA]BB+(Stable) --

Our Analysts

Analyst 1

Information Desk
bg-rating-research

Most Trending Research Reports


View More
bg-rating-rationales

Rating Rationales

icon-download

View More
Upcoming Webinars
Presentations And Recordings
28 May 2025 04:00 PM

Thermal Generation and Power Distribution – Trends & Outlook

Thermal Generation and Power Distribution – Trends & Outlook
--By Mr. Girishkumar Kadam,Mr. Vikram V
 11 days Left
icon-register
View More
08 Apr 2025 04:00 PM

ICRA Webinar on the Indian Banking Sector - Regulatory easing to support credit growth in FY2026; asset quality remains monitorable

--By Mr Karthik Srinivasan,Mr Anil Gupta,Mr Sachin Sachdeva
PPT
03 Apr 2025 04:00 PM

ICRA Webinar on Outlook FY2026

--By Mr. K Ravichandran,Ms. Aditi Nayar,Mr. Karthik Srinivasan
PPT
View More

Podcast

View More

Media Release



View More
banner-ask-expert
Ask Our Industry Analyst
Get in touch with our Business Representative
You can show error msg here
(*Denotes Compulsory field)

Submit